JP2023527613A5 - - Google Patents
Info
- Publication number
- JP2023527613A5 JP2023527613A5 JP2022551537A JP2022551537A JP2023527613A5 JP 2023527613 A5 JP2023527613 A5 JP 2023527613A5 JP 2022551537 A JP2022551537 A JP 2022551537A JP 2022551537 A JP2022551537 A JP 2022551537A JP 2023527613 A5 JP2023527613 A5 JP 2023527613A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- sequence
- chain containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062981856P | 2020-02-26 | 2020-02-26 | |
| US62/981,856 | 2020-02-26 | ||
| PCT/US2021/019775 WO2021173902A1 (en) | 2020-02-26 | 2021-02-26 | Hla class ii-restricted t cell receptors against ras with g12v mutation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023527613A JP2023527613A (ja) | 2023-06-30 |
| JP2023527613A5 true JP2023527613A5 (cg-RX-API-DMAC7.html) | 2024-03-05 |
| JP7742354B2 JP7742354B2 (ja) | 2025-09-19 |
Family
ID=74885105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551537A Active JP7742354B2 (ja) | 2020-02-26 | 2021-02-26 | G12v変異を有するrasに対するhlaクラスii拘束性t細胞受容体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230159614A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4110804A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7742354B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220143939A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115244075A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021225872A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022016661A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3169086A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2610069B (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022010157A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI900533B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021173902A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023550515A (ja) * | 2020-11-24 | 2023-12-01 | シャンハイ、ケンパーソー、バイオテクノロジー、カンパニー、リミテッド | Ras突然変異体エピトープペプチドおよびras突然変異体を認識するt細胞受容体 |
| JP2024507929A (ja) | 2021-02-25 | 2024-02-21 | アラウノス セラピューティクス インコーポレイテッド | 多シストロン性発現カセットを含む組換えベクター及びそれらの使用方法 |
| WO2022233956A1 (en) | 2021-05-05 | 2022-11-10 | Immatics Biotechnologies Gmbh | Antigen binding proteins specifically binding prame |
| WO2023150562A1 (en) | 2022-02-01 | 2023-08-10 | Alaunos Therapeutics, Inc. | Methods for activation and expansion of t cells |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8034334B2 (en) | 2002-09-06 | 2011-10-11 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| SG10201913868XA (en) * | 2015-09-15 | 2020-03-30 | The United States Of America As Represented By The Secretary | T cell receptors recognizing hla-cw8 restricted mutated kras |
| SG11201900654QA (en) * | 2016-08-02 | 2019-02-27 | Us Health | Anti-kras-g12d t cell receptors |
| AU2018335274B2 (en) * | 2017-09-20 | 2025-02-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | HLA class II–restricted T cell receptors against mutated RAS |
| MX2020005765A (es) * | 2017-12-04 | 2020-09-25 | Us Health | Receptores de celulas t restringidos a antigeno leucocitario humano (hla) clase i contra sarcoma de rata (ras) mutado. |
| US20210061876A1 (en) * | 2017-12-29 | 2021-03-04 | Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft | T cell receptors for tumor specific proteasome splice variants and uses thereof |
| GB201804724D0 (en) * | 2018-03-23 | 2018-05-09 | Univ Oslo Hf | Method of diagnosing cceliac disease |
| WO2019231326A1 (en) * | 2018-05-31 | 2019-12-05 | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n.LUMC) | Teipp neoantigens and uses thereof |
| JP2024507929A (ja) * | 2021-02-25 | 2024-02-21 | アラウノス セラピューティクス インコーポレイテッド | 多シストロン性発現カセットを含む組換えベクター及びそれらの使用方法 |
-
2021
- 2021-02-26 US US17/802,464 patent/US20230159614A1/en active Pending
- 2021-02-26 AU AU2021225872A patent/AU2021225872A1/en active Pending
- 2021-02-26 CA CA3169086A patent/CA3169086A1/en active Pending
- 2021-02-26 KR KR1020227033222A patent/KR20220143939A/ko active Pending
- 2021-02-26 EP EP21712694.5A patent/EP4110804A1/en active Pending
- 2021-02-26 TW TW110106886A patent/TWI900533B/zh active
- 2021-02-26 BR BR112022016661A patent/BR112022016661A2/pt unknown
- 2021-02-26 JP JP2022551537A patent/JP7742354B2/ja active Active
- 2021-02-26 WO PCT/US2021/019775 patent/WO2021173902A1/en not_active Ceased
- 2021-02-26 CN CN202180016761.4A patent/CN115244075A/zh active Pending
- 2021-02-26 GB GB2212195.8A patent/GB2610069B/en active Active
- 2021-02-26 MX MX2022010157A patent/MX2022010157A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021505136A5 (cg-RX-API-DMAC7.html) | ||
| JP2021191265A5 (cg-RX-API-DMAC7.html) | ||
| GB2610311A (en) | HLA class I-restricted T cell receptors against RAS with G12V mutation | |
| JP2024122980A (ja) | インターロイキン-2バリアントおよびその使用方法 | |
| Cruikshank et al. | Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. | |
| Zinkernagel et al. | Virus-induced autoantibody response to a transgenic viral antigen | |
| JP2020534828A5 (cg-RX-API-DMAC7.html) | ||
| GB2610069A (en) | HLA class II-restricted T cell receptors against RAS with G12V mutation | |
| US20150368316A1 (en) | A selective high-affinity immune stimulatory reagent and uses thereof | |
| JPH06510850A (ja) | Mhc−分子のペプチドモチーフの決定 | |
| WO2020089433A2 (en) | Tcr and peptides | |
| CN113179631B (zh) | 通过临近使能反应疗法开发的共价蛋白质药物 | |
| WO2019112347A2 (ko) | 악성 b 세포를 특이적으로 인지하는 항체 또는 그의 항원 결합 단편, 이를 포함하는 키메라 항원 수용체 및 이의 용도 | |
| CN107207622B (zh) | Hla-b27同二聚体用于癌症治疗的用途 | |
| JP2023534241A5 (cg-RX-API-DMAC7.html) | ||
| KR20210129125A (ko) | Baff-r/cd19 표적화된 키메라 항원 수용체-변형된 t 세포 및 그의 용도 | |
| JP2023544592A5 (cg-RX-API-DMAC7.html) | ||
| EA201001190A1 (ru) | Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков | |
| JP2022523024A5 (cg-RX-API-DMAC7.html) | ||
| JP7796754B2 (ja) | インターロイキン-2ムテイン及びその使用 | |
| CA2660064A1 (en) | Promiscuous pap cd4 t cell epitopes | |
| WO2014109289A9 (ja) | HLA-DR1拘束性Tax特異的CD4+T細胞エピトープ | |
| JPH08149981A (ja) | T細胞α鎖による抗原特異的免疫制御の方法 | |
| JP4624684B2 (ja) | CD28と超抗原との相互作用に基づくin−vivoにて有効な広域スペクトルの超抗原毒素アンタゴニストおよびその使用 | |
| Fehlner et al. | Murine T cell responses to melittin and its analogs |